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Introduction: We investigated prognostic parameters of patients who underwent surgical intervention for acute
mesenteric ischemia by evaluating demographic characteristics and laboratory data on admission.
Methods: The hospital records of 30 patients who underwent surgical interventions due to acute mesenteric
ischemia between January 2008 and December 2012, were reviewed retrospectively. The records were investigated
with regard to demographic data, the presence of co-morbid diseases, presenting complaints, time elapsed between
symptom onset and hospital admission, laboratory findings at admission, findings at surgical exploration, surgical
methods used, and treatment outcomes. The patients were divided into two groups, according to death (Group 1) or
survival (Group 2), and the two groups were compared in terms of the specified parameters.
Results: Of the patients, 15 were male (50%) and 15 female (50%); their mean age was 71.4 (29–94) years. Abdominal
pain was the chief complaint in all patients (100%) and mean time from pain onset to hospital admission was 21 (1–72)
h. In abdominal exploration, total small bowel (SB) ischemia and necrosis was found in 6 (20%) patients and other
patients had subtotal SB, segmental SB, segmental SB with colon, or isolated colon ischemia. Treatment in 15 patients
(50%) ended in mortality. Mean age (p = 0.038), urea (p = 0.002), AST (p < 0.001), ALT (p < 0.001), mean platelet volume
(MPV; p = 0.002), and amylase (p = 0.022) levels in Group 1 were significantly higher versus Group 2, whereas Ca
(p = 0.024) and albumin (p = 0.002) levels were significantly lower.
Conclusions: In this study, unlike other parameters that have been shown to be of prognostic significance in
mesenteric ischemia, MPV values at presentation were higher among non-survivors than survivors.
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Acute mesenteric ischemia (AMI) can result from vascu-
lar occlusive or non-occlusive conditions. Non-occlusive
mesenteric ischemia is caused by conditions such as hypo-
volemia, sepsis, and cardiogenic shock, whereas the under-
lying cause of ischemia in 70–80% of cases with AMI is
the occlusion of the superior mesenteric artery, caused by
embolism or thrombosis [1]. Irreversible changes in the
bowel mucosa occur within 6 h in the case of acute arter-
ial occlusion, leading to the disruption of the mucosal bar-
rier, which subsequently allows bacterial translocation,* Correspondence: fatihaltintoprak@yahoo.com
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article, unless otherwise stated.peritonitis, sepsis, and rapid progression to multiple organ
failure. Bowel ischemia and necrosis develop rapidly due
to a lack of sufficient time to develop collateral circulation,
particularly in cases with embolism.
Despite advances in diagnosis, treatment, and post-
operative care in recent years, AMI still has a high mortal-
ity rate, ranging between 40 and 70% [2]. The most
important causes of the high mortality include delayed
presentation, non-specific clinical findings, lack of simple
biochemical parameters that could be routinely used to
diagnose the condition early, and time loss while perform-
ing tests for differential diagnosis in patients who are not
immediately suspected to have AMI at presentation [3].
From a different perspective, if it is impossible to diagnose
AMI in the early period in most patients, it becomes moretral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this









Hematocrit (%) 40.3 38.7 41.9 >0.05
Hemoglobin (g/dl) 13.4 12.8 14.0 >0.05
Leukocyte (/μL) 16.043 18.046 14.040 >0.05
Platelet (/μL) 256.563 240.193 272.933 >0.05
MPV 8.4 9.01 7.80 0.002
Urea 76.3 102.9 51.4 0.002
Creatinine (mg/dL) 1.52 1.67 1.06 >0.05
Na 136.6 136.3 137.3 >0.05
K 4.2 4.4 3.9 >0.05
Ca 8.1 7.6 8.6 0.024
Cl 102.5 101.0 103.8 >0.05
AST (U/L) 55.63 89.9 21.3 <0.001
ALT (U/L) 60.5 100.1 20.8 <0.001
GGT 35.5 36.7 34.7 >0.05
ALP 84.6 81.0 88.9 >0.05
T.Bilirubin 1.3 1.6 0.9 >0.05
Albumin 3.2 2.6 3.8 0.002
Amylase 137.6 214.0 73.0 0.022
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useful to predict the disease course at the time of diagnosis.
The aim of the present study was to evaluate the out-
comes of surgical treatment over a period of 5 years in pa-
tients who underwent surgery with a diagnosis of AMI and
to investigate the parameters of prognostic significance.
Materials and methods
The hospital records of 30 patients who underwent surgi-
cal intervention due to acute mesenteric ischemia in the
Department of General Surgery, Sakarya University Faculty
of Medicine between January 2008 and December 2012
were reviewed retrospectively. The records were investi-
gated regarding demographic data, presence of co-morbid
diseases, presenting complaints, time elapsed between
symptom onset and hospital admission, laboratory findings
at admission, findings at surgical exploration, surgical
methods used, and treatment outcomes. The patients were
divided into two groups, according to death (Group 1) or
survival (Group 2), and they were compared in terms of
the specified parameters.
Among the parameters in complete blood counts, leuko-
cytes (WBC), hematocrit (Htc), hemoglobin (Hb), mean
platelet volume (MPV), and total platelet count (PC) were
evaluated. Among the biochemical parameters, urea, cre-
atinine, sodium (Na), potassium (K), calcium (Ca), chlor-
ine (Cl), aspartate amino transferase (AST), alanine amino
transferase (ALT), gamma glutamyl transferase (GGT), al-
kaline phosphatase (ALP), total bilirubin, albumin, and
amylase were evaluated.
Survivors in whom more than 2 years had elapsed since
their operation were contacted by phone to obtain their
latest condition.
In total, 21 variables were compared between the
groups. Student’s t-test and Fischer’s exact test were used
for comparison between subgroups. Statistical analyses
were performed using the SPSS software (ver. 16.0; SPSS,
Inc., Chicago, IL, USA). P values < 0.05 were considered to
indicate statistical significance.Results
Of the patients, 15 were male (50%) and 15 female (50%);
their mean age was 71.4 (29–94) years. Of the patients, 22
(73.3%) had a history of comorbid disease and cardiovas-
cular disorders were the most common (n = 16; 72.7%).
Abdominal pain was the chief complaint in all patients
(100%) and mean time from pain onset to hospital admis-
sion was 21 (1–72) h. All patients underwent computed
tomography (CT) of the abdomen and the use of intraven-
ous contrast agent was avoided in 5 (16.6%) patients due
to impaired renal function (creatinine > 2.5).
Hemogram and biochemical analysis results of all
patients are presented in Table 1.In the abdominal exploration, 6 (20%) patients were
found to have diffuse small bowel (SB) ischemia and
necrosis, and 17 (56.6%) had subtotal (> 100 cm) SB is-
chemia; of the 17, 8 (47.0%) had right colonic ischemia.
Five (16.6%) patients only had segmental SB ischemia
and necrosis (<100 cm) and 1 (3.3%) patient had isolated
right-sided colonic ischemia and necrosis. The operation
was terminated without performing further intervention
in patients suffering from diffuse SB ischemia and necro-
sis (total necrosis), whereas various resections were
performed in the remaining 23 patients (76.6%): 9 (9/23;
39.1%) patients underwent subtotal SB resection, 8 (8/23;
34.7%) underwent subtotal SB resection plus right hemi-
colectomy, 5 (5/23; 21.7%) underwent segmental SB re-
section, and 1 (1/23; 4.3%) patients underwent a right
hemicolectomy.
One patient (3.3%) was admitted to the hospital 1 h after
the onset of abdominal pain and CT scans showed occlu-
sion of the superior mesenteric artery (SMA). This patient
subsequently underwent an embolectomy due to the pres-
ence of subtotal ischemic changes (dark color in the
affected organs, decreased peristalsis, no pulses in the
small mesenteric arteries) in the SB but without necrosis.
Demographic features and exploration findings of the
patients are presented in Table 2.
The treatment resulted in mortality in 15 patients (50%)
(6 of them had total necrosis and underwent only explora-
tory laparotomy) and there were 15 survivors (50%),








Age 78.07 64.80 0.038
Co-morbid disease 22 12 10 >0.05
Diffuse SB ischemia 5 5 —
Diffuse SB + colon ischemia 1 1 —
Subtotal SB ischemia 10 4 6
Subtotal SB + colon ischemia 8 4 4
Segmental SB ischemia 5 1 4
Segmental SB + colon ischemia — — —
Isolated colon ischemia 1 — 1
Colon ischemia (+) 10 5 5 >0.05
Altintoprak et al. World Journal of Emergency Surgery 2013, 8:49 Page 3 of 5
http://www.wjes.org/content/8/1/49discharged after a mean follow-up of 5 days [3-12]. In a
mean follow-up period of 21 months (3–49), 2 (13.3%)
patients died for reasons other than recurrence of mes-
enteric ischemia. Among the remaining 13 patients,
only 1 (1/13; 7.6%) patient, who initially underwent an
embolectomy, was re-admitted due to the recurrence of
mesenteric ischemia at 13 months, and the patient sub-
sequently underwent a subtotal SB resection.
In comparisons of the non-survivors (group 1, n = 15)
and survivors (group 2, n = 15), mean age (p = 0.038), urea
(p = 0.002), AST (p = 0.001), MPV (p = 0.002), and amylase
(p = 0.022) levels in Group 1 were significantly higher than
in Group 2, whereas Ca (p = 0.024) and albumin (p = 0.002)
levels were significantly lower. No significant difference was
found between the groups in terms of other parameters.
Discussion
Acute mesenteric ischemia is among those rare clinical
conditions for which no significant improvement has been
achieved in the prognosis, despite advances in diagnosis
and treatment. Severe abdominal pain with a sudden onset
and indistinct physical examination findings are common
traits that could be considered to be classic for AMI.
However, this is not straightforward and requires experi-
ence to consider the diagnosis of AMI based on this clin-
ical picture. Time, which is the strongest and the most
valuable factor affecting prognosis, has already been lost
in late-presenting patients [4]. The need for radiological
imaging of a mesenteric vascular tree for a definitive
diagnosis (using multi-slice CT, multi-detector row CT
angiography, or conventional angiography), and the fact
that these methods are not always readily available con-
sume valuable time in patients presenting at an early
stage [1]. In the current study, only one patient (time to
admission = 1 h) did not show transmural ischemia and
treatment other than surgical resection was possible.
Various biochemical parameters have been investi-
gated for diagnosing acute mesenteric ischemia earlier.Leukocytosis, metabolic acidosis, elevated serum amyl-
ase levels, high lactate (L and D stereoisomers), and
high D-dimer levels can be found in the presence of
AMI. Studies have shown that these findings are not
useful in the early diagnosis of AMI and can even be el-
evated in acute abdominal conditions other than AMI
due to their low sensitivity [5-9]. Based on the assump-
tion that mucosa-derived enzymes could be used in the
early diagnosis of AMI, considering that ischemia be-
gins from the mucosa, several enzymes, such as intes-
tinal fatty acid binding protein and alpha-glutathione S
transferase, have been tested in some studies, which re-
ported limited utility [10]. Leukocytosis, metabolic acid-
osis, and elevated amylase levels were common findings
in the current study; however, these were considered to
be expected results considering the long mean time to
presentation. D-dimer and mucosa-derived enzymes are
not routinely studied in patients presenting to our clinic
with abdominal pain.
Predictive factors affecting mortality in patients with
AMI upon admission to the hospital have been analyzed
in various studies, which yielded different results for many
parameters. Aliosmanoglu et al. [11] reported a positive
correlation between mortality and leukocytosis, whereas
Mamode et al. [12] reported a correlation with leukopenia.
Sitges-Serra et al. [13] associated high urea-creatinine
levels with poor prognosis, and Aktekin et al. [3] reported
that the same parameters were higher in survivors.
Acosta-Merida et al. [14] reported an association between
hyperamylasemia and massive necrosis, whereas Unalp
et al. [15] did not report any association between hypera-
mylasemia and poor prognosis. Huang et al. [16] reported
an association between elevated aspartate aminotransfer-
ase (AST) levels and the mortality, and Aktekin et al. [3]
reported an association with elevated alanine aminotrans-
ferase (ALT) levels. In the current study, urea, AST, ALT,
and amylase levels in Group 1 were found to be signifi-
cantly higher than Group 2, whereas Ca and albumin
levels were significantly lower. These results are predict-
able, considering that late presentation was a common fea-
ture of the patients.
Many studies have described advanced age and colonic
ischemia accompanying small bowel ischemia as factors
indicating poor prognosis [14-17]. In the current study,
the mean age in Group 1 was higher than Group 2, con-
sistent with literature reports. However, accompanying co-
lonic ischemia had no effect on prognosis. This could be
explained by the small number of patients presenting with
colon involvement in the current study compared with in
previous reports.
Platelets play a critical role in the regulation of blood
flow and thrombogenic cascades. MPV is a marker of
the size and activation of platelets, and elevated levels of
MPV reflect increased production and activation of
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enzymatic activity, and show higher thrombogenic po-
tential [18]. Several molecules released from activated
platelets, such as P-selectin and thromboxane A2, con-
tribute to thrombus formation; activated platelets also
attach to endothelium and up-regulate the expression of
adhesions molecules [19]. It was thought that increased
MPV could be associated with increased vascular inflam-
mation and thrombogenicity, and a direct association has
been shown between increased MPV and acute throm-
botic events, such as acute myocardial infarction, unstable
angina, and stroke [20-22]. Furthermore, increased MPV
was found to be an independent predictor factor of mor-
tality in ischemic vascular events, recurrent myocardial
infarction, and coronary artery disease [23].
No published study has examined the relationship be-
tween MPV and AMI. AMI is a cardiovascular disease in
origin, although its consequences affect predominantly the
gastrointestinal system. As a matter of course, a relation-
ship between AMI and increased MPV is considered to in-
dicate increased thrombogenic activity. In the current
study, MPV in Group 1 was significantly higher than in
Group 2.
However, it would not be appropriate to consider that
this result indicates that “increased MPV is a predictive
factor for prognosis in AMI,” because a high MPV is
found in other atherosclerosis-related conditions (such
as diabetes mellitus, hypertension, hypercholesterol-
emia, smoking, and obesity) [24]. High mean age and
the presence of co-morbid conditions related to the car-
diovascular system in most of our patients suggest that
these patients might have had a high MPV before the
development of AMI.
Considering the significantly higher MPV in Group 1
in the current study: 1) MPV could be used to predict
the potential for vascular damage in other organs, such
as the liver and kidneys (that is, to identify candidate
multi-organ failure patients), and 2) because it reflects a
tendency for thrombosis, MPV could be useful to justify
re-operation when a second-look decision could not be
made otherwise.
In conclusion, AMI continues to have a high mortality
rate despite advances in diagnosis, treatment, and post-
operative care. MPV can be beneficial in predicting
patients with poor prognosis and in the planning of re-
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